Vir Biotechnology VIR
NASDAQ VIR
$11.14 +0.49 (+4.60%)
As of: Sep 30, 2026 · 1:38 PM EDT

Vir Biotechnology, Inc. (VIR) EV to CFO (2022 - 2023)

Updated

Vir Biotechnology's (VIR) EV to CFO stood at 0.90 in Q1 2023, down 75.8% from 3.70 a year earlier but up 48.8% from the prior quarter.

Analysis

Vir Biotechnology, Inc. (VIR) EV to CFO (2022 - 2023) Analysis & Trends

On a TTM basis, Vir Biotechnology's EV to CFO came in at -6.04 as of Mar 31, 2023; for FY2022, it was 0.60.

  • Quarterly EV to CFO has ranged from 0.15 in Q3 2022 to 3.70 in Q1 2022 over the past five years.
  • Per Business Quant, the preceding three quarters came in at 0.60 (Q4 2022), 0.15 (Q3 2022) and 0.86 (Q2 2022).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 0.90
Dec 31, 2022 0.60
Sep 30, 2022 0.15
Jun 30, 2022 0.86
Mar 31, 2022 3.70
API Access

Vir Biotechnology, Inc. EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=VIR&period=max&api_key=YOUR_API_KEY